News

Latest news

2025

Oct 2, 2025
From koalas to humans: How Australia’s vaccine win can help us beat human chlamydia.

2024

Oct 10, 2024
Ziphius Announces Appointment of Damien Dessis as Chief Business Officer (CBO)
May 31, 2024
Ziphius Appoints Trudy Vanhove as Non-Executive Director and Announces New York Office Opening
May 24, 2024
Ziphius Extends Board with former VIB Managing Director Jo Bury as non-executive Director and Chairman

2023

Jan 13, 2023
Ziphius Vaccines Appoints Former Head of Janssen Vaccines R&D as Chief Scientific Advisor

2022

Oct 7, 2022
Ziphius Vaccines and UZ Ghent Establish Unique Collaboration for GMP Manufacturing of saRNA-Based Vaccines
Jun 23, 2022
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Jun 9, 2022
Ziphius Vaccines and University of Antwerp Announce Collaboration Agreement for Optimized Delivery of saRNA-based Vaccines & Therapeutics
May 6, 2022
Ziphius Vaccines and Ghent University Publish Promising Data from self-amplifying RNA Platform in Molecular Therapy

2021

Sep 21, 2021
Ziphius Vaccines Accelerates its Promising sa-RNA Program with Two Senior Executive Appointments
May 25, 2021
Ziphius Vaccines Raises €29.3M in Oversubscribed Series A Financing
Jan 11, 2021
Ziphius Vaccines strengthens Leadership Team and provides Business Update

Events

Upcoming

There are no upcoming events at this time.

Events

Past

-
Bio-Europe 2025
Vienna, Austria
-
World Vaccine Congress Europe
Amsterdam, Netherlands
-
BioJapan 2025
Yokahama, Japan
-
BIO US
Boston, USA
Bio NJ
New Jersey, USA
-
Bio€quite Europe
Bruges, Belgium
Knowledge For Growth
Antwerp, Belgium
-
LSX Congress
London, UK
-
World Vaccine Congress
Washington, USA
-
Venture Summit West
Silicon Valley, CA, USA
-
BioTrinity
London, UK
-
BIO-Europe Spring
Milan, Italy
-
BIO CEO Investor Conference
New York, USA
-
HealthTech Investor Summit
Brugge, Belgium
-
BioFit
Lille, France